Oppenheimer Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Buy |
11,510
+1,016
| +10% | +$275K | 0.04% | 454 |
|
|
2025
Q4 | $2.63M | Buy |
10,494
+270
| +3% | +$71.7K | 0.03% | 453 |
|
|
2025
Q3 | $2.93M | Sell |
10,224
-2,230
| -18% | -$597K | 0.03% | 460 |
|
|
2025
Q2 | $3.27M | Sell |
12,454
-102
| -0.8% | -$24.8K | 0.04% | 436 |
|
|
2025
Q1 | $2.92M | Sell |
12,556
-224
| -2% | -$54.4K | 0.04% | 439 |
|
|
2024
Q4 | $2.93M | Buy |
12,780
+45
| +0.4% | +$10.3K | 0.04% | 442 |
|
|
2024
Q3 | $2.85M | Buy |
12,735
+470
| +4% | +$103K | 0.03% | 451 |
|
|
2024
Q2 | $2.5M | Buy |
12,265
+2,725
| +29% | +$554K | 0.03% | 470 |
|
|
2024
Q1 | $2.08M | Sell |
9,540
-654
| -6% | -$144K | 0.03% | 470 |
|
|
2023
Q4 | $2.32M | Sell |
10,194
-331
| -3% | -$69.5K | 0.03% | 470 |
|
|
2023
Q3 | $2.12M | Sell |
10,525
-73
| -0.7% | -$15.4K | 0.03% | 471 |
|
|
2023
Q2 | $2.2M | Buy |
10,598
+725
| +7% | +$141K | 0.03% | 476 |
|
|
2023
Q1 | $1.95M | Sell |
9,873
-594
| -6% | -$122K | 0.03% | 499 |
|
|
2022
Q4 | $2.12M | Buy |
10,467
+7,360
| +237% | +$1.44M | 0.03% | 461 |
|
|
2022
Q3 | $546K | Buy |
3,107
+200
| +7% | +$40.9K | 0.01% | 811 |
|
|
2022
Q2 | $585K | Sell |
2,907
-263
| -8% | -$56.1K | 0.01% | 814 |
|
|
2022
Q1 | $718K | Buy |
3,170
+156
| +5% | +$36.7K | 0.01% | 834 |
|
|
2021
Q4 | $814K | Buy |
3,014
+17
| +0.6% | +$4.21K | 0.01% | 839 |
|
|
2021
Q3 | $724K | Buy |
2,997
+271
| +10% | +$68.3K | 0.01% | 838 |
|
|
2021
Q2 | $646K | Buy |
2,726
+256
| +10% | +$58.3K | 0.01% | 879 |
|
|
2021
Q1 | $541K | Sell |
2,470
-645
| -21% | -$129K | 0.01% | 892 |
|
|
2020
Q4 | $545K | Buy |
3,115
+7
| +0.2% | +$1.21K | 0.01% | 852 |
|
|
2020
Q3 | $502K | Sell |
3,108
-223
| -7% | -$35.3K | 0.01% | 811 |
|
|
2020
Q2 | $476K | Sell |
3,331
-431
| -11% | -$59.6K | 0.01% | 808 |
|
|
2020
Q1 | $407K | Sell |
3,762
-184
| -5% | -$26.5K | 0.01% | 792 |
|
|
2019
Q4 | $574K | Sell |
3,946
-6
| -0.2% | -$866 | 0.01% | 782 |
|
|
2019
Q3 | $570K | Buy |
3,952
+338
| +9% | +$49.3K | 0.01% | 772 |
|
|
2019
Q2 | $537K | Buy |
3,614
+169
| +5% | +$23.6K | 0.01% | 795 |
|
|
2019
Q1 | $453K | Buy |
3,445
+479
| +16% | +$59K | 0.01% | 829 |
|
|
2018
Q4 | $322K | Buy |
2,966
+752
| +34% | +$101K | 0.01% | 881 |
|
|
2018
Q3 | $331K | Buy |
2,214
+218
| +11% | +$33.2K | 0.01% | 932 |
|
|
2018
Q2 | $308K | Buy |
1,996
+60
| +3% | +$9.06K | 0.01% | 934 |
|
|
2018
Q1 | $269K | Buy |
1,936
+209
| +12% | +$30.7K | 0.01% | 966 |
|
|
2017
Q4 | $224K | Hold |
1,727
| – | – | 0.01% | 1016 |
|
|
2017
Q3 | $224K | Sell |
1,727
-102
| -6% | -$13.6K | 0.01% | 1021 |
|
|
2017
Q2 | $242K | Buy |
1,829
+133
| +8% | +$16.3K | 0.01% | 981 |
|
|
2017
Q1 | $208K | Buy |
+1,696
| New | +$201K | 0.01% | 1040 |
|
Other funds holding LH
VCM
VPM
Oppenheimer Asset Management's LH Position: Q1 2026 in Review
Oppenheimer Asset Management increased its Labcorp (LH) stake by 9.7% in Q1 2026, buying an estimated $275K and bringing the position to 11,510 shares worth $3.07M. The position accounts for 0.04% of the portfolio, ranked #454.
Oppenheimer Asset Management first reported a position in LH in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.27M in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Oppenheimer Asset Management held 11,510 shares of Labcorp worth $3.07M as of Q1 2026.
- Oppenheimer Asset Management bought 1,016 Labcorp shares in Q1 2026, an estimated $275K.
- Labcorp made up 0.04% of Oppenheimer Asset Management's portfolio in Q1 2026, its #454 holding.
- Oppenheimer Asset Management first reported a position in Labcorp in Q1 2017 and has held it in 37 quarters since.
- Oppenheimer Asset Management's Labcorp position peaked at $3.27M in Q2 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.